• English
  • Korean
  • Chinese
表紙
市場調査レポート - 235295

網膜静脈閉塞:世界の治験レビュー

Retinal Vein Occlusion Global Clinical Trials Review, H1, 2013

発行 GlobalData
出版日 ページ情報 英文 217 Pages
電子版即納可
価格
網膜静脈閉塞:世界の治験レビュー Retinal Vein Occlusion Global Clinical Trials Review, H1, 2013
出版日: 2013年03月31日 ページ情報: 英文 217 Pages
概要

当レポートでは、世界の網膜静脈閉塞治療薬の臨床試験について調査し、地域別の臨床市件数データ、試験段階、試験状況、採用テーマおよびスポンサー企業タイプ別の臨床試験データ、中断(一時中止、廃止、打ち切り)された試験のリストなどを提供しており、概略以下の構成でお届けします。

目次

  • イントロダクション
    • 網膜静脈閉塞
    • レポートガイダンス
  • 臨床試験:地域別
  • 臨床試験:国別
    • 臨床試験に寄与している主要5ヵ国 − アジア太平洋地域
    • 臨床試験に寄与している主要5ヵ国 − 欧州
    • 臨床試験に寄与している主要国 − 北米
    • 臨床試験に寄与している主要国 − 中東およびアフリカ
    • 臨床試験に寄与している主要国 − 中南米
  • 臨床試験 BRIC 諸国
  • 臨床試験 G7 諸国
  • 臨床試験 G7 諸国 , 治験ステータス別
  • 臨床試験 E7 諸国
  • 臨床試験 E7 諸国 , 治験ステータス別
  • 相別臨床試験
    • 進行中の治験:相別
  • 臨床試験:治験ステータス別
  • 未完了の治験
  • 期間ごとの被験者数
  • 有力なスポンサー
    • 主な治験参加企業
  • 有望な治療薬比較
  • 臨床試験プロファイル
    • 臨床試験概要:主要企業
      • Allergan, Inc.
      • Genentech, Inc.
      • Regeneron Pharmaceuticals, Inc.
      • Okuvision GmbH
      • Mid Atlantic Retina
      • Aleris Helse AS
      • Retina Associates of Cleveland, Inc.
      • Alimera Sciences, Inc.
      • Fovea Pharmaceuticals SA
      • 三和化学研究所
      • Bayer AG
      • Novartis AG
      • 参天製薬
      • Eyetech Pharmaceuticals, Inc.
      • F. Hoffmann-La Roche Ltd.
    • 臨床試験概要:トップレベルの大学 / 研究機関 / 病院
      • 京都大学
      • Johns Hopkins University
      • Barnes Retina Institute
      • University of Toronto
      • Shaheed Beheshti Medical University
      • Duke University
      • Medical University of Vienna
      • Yonsei University
      • St. Erik Eye Hospital
      • 滋賀医科大学
      • California Retina Consultants
      • Manhattan Eye Ear & Throat Hospital
      • 山形大学医学部附属病院
      • Retina Macula Institute
      • Instituto Universitario de of talmobiologia Aplicada
      • Midwest Eye-Banks
      • Baqiyatallah Medical Sciences University
      • Stavanger University Hospital
      • Shiraz University of Medical Sciences
      • University of Leipzig
  • 5件の主要臨床プロファイル

付録

図表一覧


このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次

Summary

GlobalData's clinical trial report, "Retinal Vein Occlusion Global Clinical Trials Review, H1, 2013" provides data on the Retinal Vein Occlusion clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Retinal Vein Occlusion. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Retinal Vein Occlusion. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Retinal Vein Occlusion
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by BRIC Nations
  • Clinical Trials by G7 Nations
  • Clinical Trials in G7 Nations by Trial Status
  • Clinical Trials by E7 Nations
  • Clinical Trials in E7 Nations by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Unaccomplished Trials of Retinal Vein Occlusion
  • Subjects Recruited Over a Period of Time
  • Prominent Sponsors
    • Top Companies Participating in Retinal Vein Occlusion Therapeutics Clinical Trials
  • Prominent Drug Comparison
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Allergan, Inc.
      • Clinical Trial Overview of Allergan, Inc.
      • Novartis AG
      • Clinical Trial Overview of Novartis AG
      • Genentech, Inc.
      • Clinical Trial Overview of Genentech, Inc.
      • Novartis Pharmaceuticals Corporation
      • Clinical Trial Overview of Novartis Pharmaceuticals Corporation
      • Regeneron Pharmaceuticals, Inc.
      • Clinical Trial Overview of Regeneron Pharmaceuticals, Inc.
      • Mid Atlantic Retina
      • Clinical Trial Overview of Mid Atlantic Retina
      • Chengdu Kanghong Pharmaceuticals Group Co., Ltd.
      • Clinical Trial Overview of Chengdu Kanghong Pharmaceuticals Group Co., Ltd.
      • Aleris Helse AS
      • Clinical Trial Overview of Aleris Helse AS
      • Opocrin S.p.A
      • Clinical Trial Overview of Opocrin S.p.A
      • Retina Associates of Cleveland, Inc.
      • Clinical Trial Overview of Retina Associates of Cleveland, Inc.
      • Icon Bioscience, Inc.
      • Clinical Trial Overview of Icon Bioscience, Inc.
      • The EMMES Corporation
      • Clinical Trial Overview of The EMMES Corporation
      • Alimera Sciences, Inc.
      • Clinical Trial Overview of Alimera Sciences, Inc.
      • ARCA biopharma, Inc.
      • Clinical Trial Overview of ARCA biopharma, Inc.
      • Fovea Pharmaceuticals SA
      • Clinical Trial Overview of Fovea Pharmaceuticals SA
      • Sanwa Kagaku Kenkyusho Co., Ltd.
      • Clinical Trial Overview of Sanwa Kagaku Kenkyusho Co., Ltd.
      • Bayer AG
      • Clinical Trial Overview of Bayer AG
      • Santen Pharmaceutical Co., Ltd.
      • Clinical Trial Overview of Santen Pharmaceutical Co., Ltd.
      • Eyetech Pharmaceuticals, Inc.
      • Clinical Trial Overview of Eyetech Pharmaceuticals, Inc.
      • Valeant Pharmaceuticals International, Inc.
      • Clinical Trial Overview of Valeant Pharmaceuticals International, Inc.
    • Clinical Trial Overview of Top Universities / Institutes / Hospitals
      • Shaheed Beheshti Medical University
      • Clinical Trial Overview of Shaheed Beheshti Medical University
      • Kyoto University
      • Clinical Trial Overview of Kyoto University
      • Johns Hopkins University
      • Clinical Trial Overview of Johns Hopkins University
      • University of Toronto
      • Clinical Trial Overview of University of Toronto
      • Barnes Retina Institute
      • Clinical Trial Overview of Barnes Retina Institute
      • S:t Eriks Ogonsjukhus AB
      • Clinical Trial Overview of S:t Eriks Ogonsjukhus AB
      • Shiga University of Medical Science
      • Clinical Trial Overview of Shiga University of Medical Science
      • Duke University
      • Clinical Trial Overview of Duke University
      • Medical University of Vienna
      • Clinical Trial Overview of Medical University of Vienna
      • Ludwig-Maximilians-Universitat Munich
      • Clinical Trial Overview of Ludwig-Maximilians-Universitat Munich
      • California Retina Consultants
      • Clinical Trial Overview of California Retina Consultants
      • Asociacion para Evitar la Ceguera en Mexico I.A.P.
      • Clinical Trial Overview of Asociacion para Evitar la Ceguera en Mexico I.A.P.
      • Manhattan Eye Ear & Throat Hospital
      • Clinical Trial Overview of Manhattan Eye Ear & Throat Hospital
      • Yamagata University Hospital
      • Clinical Trial Overview of Yamagata University Hospital
      • Keio University Hospital
      • Clinical Trial Overview of Keio University Hospital
      • Stavanger University Hospital
      • Clinical Trial Overview of Stavanger University Hospital
      • The University of Chicago
      • Clinical Trial Overview of The University of Chicago
      • Shiraz University of Medical Sciences
      • Clinical Trial Overview of Shiraz University of Medical Sciences
      • Hospital Universitario Ramon y Cajal
      • Clinical Trial Overview of Hospital Universitario Ramon y Cajal
      • The Medical University of Graz
      • Clinical Trial Overview of The Medical University of Graz
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Retinal Vein Occlusion Therapeutics Market, Global, Clinical Trials by Zone, 2013*
  • Retinal Vein Occlusion Therapeutics Market, Global, Clinical Trials by Top Countries, 2013*
  • Retinal Vein Occlusion Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013*
  • Retinal Vein Occlusion Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2013*
  • Retinal Vein Occlusion Therapeutics Clinical Trials, Europe, Top Five Countries, 2013*
  • Retinal Vein Occlusion Therapeutics Clinical Trials, North America, Top Countries, 2013*
  • Retinal Vein Occlusion Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2013*
  • Retinal Vein Occlusion Therapeutics Clinical Trials, Central and South America, Top Countries, 2013*
  • Retinal Vein Occlusion Therapeutics Clinical Trials, BRIC Countries, 2013*
  • Retinal Vein Occlusion Therapeutics Clinical Trials, G7 Countries, 2013*
  • Retinal Vein Occlusion Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013*
  • Retinal Vein Occlusion Therapeutics Clinical Trials, E7 Countries, 2013*
  • Retinal Vein Occlusion Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013*
  • Retinal Vein Occlusion Therapeutics Market, Global, Clinical Trials by Phase, 2013*
  • Retinal Vein Occlusion Therapeutics Market, Global, Clinical Trials In Progress by Phase 2013*
  • Retinal Vein Occlusion Therapeutics Market, Global, Clinical Trials by Trial Status, 2013*
  • Retinal Vein Occlusion Therapeutics Market, Global, Suspended Clinical Trials, 2013*
  • Retinal Vein Occlusion Therapeutics Market, Global, Withdrawn Clinical Trials, 2013*
  • Retinal Vein Occlusion Therapeutics Market, Global, Terminated Clinical Trials, 2013*
  • Retinal Vein Occlusion Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012
  • Retinal Vein Occlusion Therapeutics Clinical Trials, Global, Key Sponsors, 2013*
  • Retinal Vein Occlusion Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013*
  • Retinal Vein Occlusion Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013*
  • Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Allergan, Inc., 2013*
  • Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2013*
  • Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Genentech, Inc., 2013*
  • Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis Pharmaceuticals Corporation, 2013*
  • Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Regeneron Pharmaceuticals, Inc., 2013*
  • Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Mid Atlantic Retina, 2013*
  • Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Chengdu Kanghong Pharmaceuticals Group Co., Ltd., 2013*
  • Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Aleris Helse AS, 2013*
  • Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Opocrin S.p.A, 2013*
  • Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Retina Associates of Cleveland, Inc., 2013*
  • Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Icon Bioscience, Inc., 2013*
  • Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by The EMMES Corporation, 2013*
  • Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Alimera Sciences, Inc., 2013*
  • Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by ARCA biopharma, Inc., 2013*
  • Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Fovea Pharmaceuticals SA, 2013*
  • Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanwa Kagaku Kenkyusho Co., Ltd., 2013*
  • Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2013*
  • Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Santen Pharmaceutical Co., Ltd., 2013*
  • Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Eyetech Pharmaceuticals, Inc., 2013*
  • Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Valeant Pharmaceuticals International, Inc., 2013*
  • Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Shaheed Beheshti Medical University, 2013*
  • Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Kyoto University, 2013*
  • Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Johns Hopkins University, 2013*
  • Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Toronto, 2013*
  • Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Barnes Retina Institute, 2013*
  • Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by S:t Eriks Ogonsjukhus AB, 2013*
  • Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Shiga University of Medical Science, 2013*
  • Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2013*
  • Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Vienna, 2013*
  • Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Ludwig-Maximilians-Universitat Munich, 2013*
  • Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by California Retina Consultants, 2013*
  • Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Asociacion para Evitar la Ceguera en Mexico I.A.P., 2013*
  • Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Manhattan Eye Ear & Throat Hospital, 2013*
  • Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Yamagata University Hospital, 2013*
  • Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Keio University Hospital, 2013*
  • Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Stavanger University Hospital, 2013*
  • Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Chicago, 2013*
  • Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Shiraz University of Medical Sciences, 2013*
  • Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Hospital Universitario Ramon y Cajal, 2013*
  • Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by The Medical University of Graz, 2013*

List of Figures

  • Retinal Vein Occlusion Therapeutics Market, Global, Clinical Trials by Zone (%), 2013*
  • Retinal Vein Occlusion Therapeutics Market, Global, Clinical Trials by Top Countries, 2013*
  • Retinal Vein Occlusion Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013*
  • Retinal Vein Occlusion Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2013*
  • Retinal Vein Occlusion Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2013*
  • Retinal Vein Occlusion Therapeutics Clinical Trials, North America, Top Countries (%), 2013*
  • Retinal Vein Occlusion Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2013*
  • Retinal Vein Occlusion Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2013*
  • Retinal Vein Occlusion Therapeutics Clinical Trials, BRIC Countries (%), 2013*
  • Retinal Vein Occlusion Therapeutics Clinical Trials, G7 Countries (%), 2013*
  • Retinal Vein Occlusion Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013*
  • Retinal Vein Occlusion Therapeutics Clinical Trials, E7 Countries (%), 2013*
  • Retinal Vein Occlusion Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013*
  • Retinal Vein Occlusion Therapeutics Market, Global, Clinical Trials by Phase (%), 2013*
  • Retinal Vein Occlusion Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2013*
  • Retinal Vein Occlusion Therapeutics Market, Global, Clinical Trials by Trial Status, 2013*
  • Retinal Vein Occlusion Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012
  • Retinal Vein Occlusion Therapeutics Clinical Trials, Global, Key Sponsors, 2013*
  • Retinal Vein Occlusion Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013*
  • Retinal Vein Occlusion Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013*
  • GlobalData Methodology
Back to Top